Puylaert Kevin 4
4 · SOPHiA GENETICS SA · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CSO Kevin Puylaert Sells 33 Shares
What Happened Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA (SOPH), sold 33 shares on 2026-03-19 at $4.76 per share, generating proceeds of approximately $157. The sale was reported on a Form 4 filed 2026-03-20 and was a disposition (sale) rather than a purchase.
Key Details
- Transaction date: 2026-03-19; filing date: 2026-03-20 (timely filed).
- Sale: 33 shares at $4.76 per share; total proceeds ≈ $157.
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnote: The shares were sold in the open market as a "sell-to-cover" to satisfy tax withholding related to RSUs that vested on 2026-03-18. The sale was not a discretionary trade.
- Transaction code: S (Sale); tax withholding indicated (footnote F1).
Context Sell-to-cover transactions are routine tax-withholding actions when restricted stock units vest and do not necessarily indicate the insider's view on the company's prospects. Purchases generally carry more weight for signaling, while small withholding sales like this are common and procedural.
Insider Transaction Report
Form 4
Puylaert Kevin
Chief Sales Officer
Transactions
- Sale
Ordinary Shares
[F1]2026-03-19$4.76/sh−33$157→ 92,386 total
Footnotes (1)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on March 18, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Kevin Puylaert|2026-03-20